|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ma D, Li S, Cui Y, Li L, Liu H, Chen Y and
Zhou X: Paclitaxel increases the sensitivity of lung cancer cells
to lobaplatin via PI3K/Akt pathway. Oncol Lett. 15:6211–6216.
2018.PubMed/NCBI
|
|
3
|
Warth A, Muley T, Meister M, Stenzinger A,
Thomas M, Schirmacher P, Schnabel PA, Budczies J, Hoffmann H and
Weichert W: The novel histologic International Association for the
Study of Lung Cancer/American Thoracic Society/European Respiratory
Society classification system of lung adenocarcinoma is a
stage-independent predictor of survival. J Clin Oncol.
30:1438–1446. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Molina JR, Yang P, Cassivi SD, Schild SE
and Adjei AA: Non-small cell lung cancer: Epidemiology, risk
factors, treatment, and survivorship. Mayo Clin Proc. 83:584–594.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Herbst RS, Morgensztern D and Boshoff C:
The biology and management of non-small cell lung cancer. Nature.
553:446–454. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The Rosetta Stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tay Y, Kats L, Salmena L, Weiss D, Tan SM,
Ala U, Karreth F, Poliseno L, Provero P, Di Cunto F, et al:
Coding-independent regulation of the tumor suppressor PTEN by
competing endogenous mRNAs. Cell. 147:344–357. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang R, Xing L, Zheng X, Sun Y, Wang X and
Chen J: The circRNA circAGFG1 acts as a sponge of miR-195-5p to
promote triple-negative breast cancer progression through
regulating CCNE1 expression. Mol Cancer. 18:42019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Su H, Tao T, Yang Z, Kang X, Zhang X, Kang
D, Wu S and Li C: Circular RNA cTFRC acts as the sponge of
MicroRNA-107 to promote bladder carcinoma progression. Mol Cancer.
18:272019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tay Y, Karreth FA and Pandolfi PP:
Aberrant ceRNA activity drives lung cancer. Cell Res. 24:259–260.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li L, Peng M, Xue W, Fan Z, Wang T, Lian
J, Zhai Y, Lian W, Qin D and Zhao J: Integrated analysis of
dysregulated long non-coding RNAs/microRNAs/mRNAs in metastasis of
lung adenocarcinoma. J Transl Med. 16:3722018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li DS, Ainiwaer JL, Sheyhiding I, Zhang Z
and Zhang LW: Identification of key long non-coding RNAs as
competing endogenous RNAs for miRNA-mRNA in lung adenocarcinoma.
Eur Rev Med Pharmacol Sci. 20:2285–2295. 2016.PubMed/NCBI
|
|
13
|
Dong HX, Wang R, Jin XY, Zeng J and Pan J:
lncRNA DGCR5 promotes lung adenocarcinoma (LUAD) progression via
inhibiting hsa-mir-22-3p. J Cell Physiol. 233:4126–4136. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xiong DD, Li ZY, Liang L, He RQ, Ma FC,
Luo DZ, Hu XH and Chen G: The LncRNA NEAT1 Accelerates Lung
Adenocarcinoma Deterioration and Binds to Mir-193a-3p as a
Competitive Endogenous RNA. Cell Physiol Biochem. 48:905–918. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cheng C, Zhang Z, Cheng F and Shao Z:
Exosomal lncRNA RAMP2-AS1 Derived from Chondrosarcoma Cells
Promotes Angiogenesis Through miR-2355-5p/VEGFR2 Axis. OncoTargets
Ther. 13:3291–3301. 2020. View Article : Google Scholar
|
|
16
|
Li JH, Liu S, Zhou H, Qu LH and Yang JH:
starBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA
interaction networks from large-scale CLIP-Seq data. Nucleic Acids
Res. 42D:D92–D97. 2014. View Article : Google Scholar
|
|
17
|
Andrews MC, Cursons J, Hurley DG, Anaka M,
Cebon JS, Behren A and Crampin EJ: Systems analysis identifies
miR-29b regulation of invasiveness in melanoma. Mol Cancer.
15:722016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang H, Zhao Y, Chen T, Liu G, He N and Hu
H: miR-371 promotes proliferation and metastasis in hepatocellular
carcinoma by targeting PTEN. BMB Rep. 52:312–317. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang Z, Wu L, Wang A, Tang W, Zhao Y, Zhao
H and Teschendorff AE: dbDEMC 2.0: Updated database of
differentially expressed miRNAs in human cancers. Nucleic Acids
Res. 45D:D812–D818. 2017. View Article : Google Scholar
|
|
20
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res.
45W:W98–W102. 2017. View Article : Google Scholar
|
|
21
|
Chandrashekar DS, Bashel B, Balasubramanya
SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK and
Varambally S: UALCAN: A Portal for Facilitating Tumor Subgroup Gene
Expression and Survival Analyses. Neoplasia. 19:649–658. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fouad TM, Barrera AMG, Reuben JM, Lucci A,
Woodward WA, Stauder MC, Lim B, DeSnyder SM, Arun B, Gildy B, et
al: Inflammatory breast cancer: A proposed conceptual shift in the
UICC-AJCC TNM staging system. Lancet Oncol. 18:e228–e232. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shin J, Shin S, Lee JH, Song KB, Hwang DW,
Kim HJ, Byun JH, Cho H, Kim SC and Hong SM: Lymph node size and its
association with nodal metastasis in ductal adenocarcinoma of the
pancreas. J Pathol Transl Med. 54:387–395. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nagy Á, Lánczky A, Menyhárt O and Győrffy
B: Validation of miRNA prognostic power in hepatocellular carcinoma
using expression data of independent datasets. Sci Rep. 8:92272018.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gao J, Aksoy BA, Dogrusoz U, Dresdner G,
Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al:
Integrative analysis of complex cancer genomics and clinical
profiles using the cBioPortal. Sci Signal. 6:pl12013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pathan M, Keerthikumar S, Ang CS, Gangoda
L, Quek CY, Williamson NA, Mouradov D, Sieber OM, Simpson RJ, Salim
A, et al: FunRich: An open access standalone functional enrichment
and interaction network analysis tool. Proteomics. 15:2597–2601.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Szklarczyk D, Morris JH, Cook H, Kuhn M,
Wyder S, Simonovic M, Santos A, Doncheva NT, Roth A, Bork P, et al:
The STRING database in 2017: Quality-controlled protein-protein
association networks, made broadly accessible. Nucleic Acids Res.
45D:D362–D368. 2017. View Article : Google Scholar
|
|
28
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Qiu M, Xu Y, Wang J, Zhang E, Sun M, Zheng
Y, Li M, Xia W, Feng D, Yin R, et al: A novel lncRNA, LUADT1,
promotes lung adenocarcinoma proliferation via the epigenetic
suppression of p27. Cell Death Dis. 6:e18582015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shang J, Wang Z, Chen W, Yang Z, Zheng L,
Wang S and Li S: Pseudogene CHIAP2 inhibits proliferation and
invasion of lung adenocarcinoma cells by means of the WNT pathway.
J Cell Physiol. 234:13735–13746. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mao S, Li Y, Lu Z, Che Y, Huang J, Lei Y,
Wang Y, Liu C, Wang X, Zheng S, et al: PHD finger protein 5A
promoted lung adenocarcinoma progression via alternative splicing.
Cancer Med. 8:2429–2441. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu S, Mitra R, Zhao MM, Fan W, Eischen
CM, Yin F and Zhao Z: The Potential Roles of Long Noncoding RNAs
(lncRNA) in Glioblastoma Development. Mol Cancer Ther.
15:2977–2986. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhou SL, Tang QL, Zhou SX and Ren RZ:
miR-296-5p suppresses papillary thyroid carcinoma cell growth via
targeting PLK1. Eur Rev Med Pharmacol Sci. 23:2084–2091.
2019.PubMed/NCBI
|
|
35
|
Li S, Zheng H, Chen L, Xu C, Qu X, Qin Z,
Gao J, Li J and Liu J: Expression Profile and Potential Functions
of Circulating Long Noncoding RNAs in Acute Ischemic Stroke in the
Southern Chinese Han Population. Front Mol Neurosci. 12:2902019.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang P, Ning S, Zhang Y, Li R, Ye J, Zhao
Z, Zhi H, Wang T, Guo Z and Li X: Identification of
lncRNA-associated competing triplets reveals global patterns and
prognostic markers for cancer. Nucleic Acids Res. 43:3478–3489.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li Y, Ding X, Xiu S, Du G and Liu Y:
LncRNA NEAT1 Promotes Proliferation, Migration And Invasion Via
Regulating miR-296-5p/CNN2 Axis In Hepatocellular Carcinoma Cells.
OncoTargets Ther. 12:9887–9897. 2019. View Article : Google Scholar
|
|
38
|
Chen Y, Gao H and Li Y: Inhibition of
LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of
thyroid cancer via elevating miR-296-5p and inactivating
TGF-β1/Smads signaling pathway. Mol Cell Endocrinol.
500:1106342020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Choi JS, Cho BH, Kim HJ, Kim YM and Jang
JH: Identification of new genes of pleomorphic adenoma. Medicine
(Baltimore). 98:e184682019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Spiombi E, Angrisani A, Fonte S, De Feudis
G, Fabretti F, Cucchi D, Izzo M, Infante P, Miele E, Po A, et al:
KCTD15 inhibits the Hedgehog pathway in Medulloblastoma cells by
increasing protein levels of the oncosuppressor KCASH2.
Oncogenesis. 8:642019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Bonner K, Borlay D, Kutten O and Quick QA:
Inhibition of the Spectraplakin Protein Microtubule Actin
Crosslinking Factor 1 Sensitizes Glioblastomas to Radiation. Brain
Tumor Res Treat. 8:43–52. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Afghani N, Mehta T, Wang J, Tang N, Skalli
O and Quick QA: Microtubule actin cross-linking factor 1, a novel
target in glioblastoma. Int J Oncol. 50:310–316. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Prieske K, Alawi M, Oliveira-Ferrer L,
Jaeger A, Eylmann K, Burandt E, Schmalfeldt B, Joosse SA and
Woelber L: Genomic characterization of vulvar squamous cell
carcinoma. Gynecol Oncol. 158:547–554. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Mallmann-Gottschalk N, Sax Y, Kimmig R,
Lang S and Brandau S: EGFR-Specific Tyrosine Kinase Inhibitor
Modifies NK Cell-Mediated Antitumoral Activity against Ovarian
Cancer Cells. Int J Mol Sci. 20:202019. View Article : Google Scholar
|
